NZ

Nuzhat Zeba Rehan Akhtar Ansari

Active Director Director DIN 11133215
DIN 11133215 First appointment May 2025 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Nuzhat Zeba Rehan Akhtar Ansari

Data last updated:

Nuzhat Zeba Rehan Akhtar Ansari is a Director at Certus Medicinus Systems Private Limited (since 2025). The company operates in Healthcare.

DIN 11133215
Primary Designation Director
Industry Healthcare
First Appointment 30 May 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director30 May 20252025Active

Board colleagues of Nuzhat Zeba Rehan Akhtar Ansari

NameDINCompanyDesignation
Jyoti Aggarwal11133214Certus Medicinus Systems Private LimitedDirector

Directorship timeline

Open interactive timeline →
Certus Medicinus Systems Private Limited
Premium access

Shareholding and investment profile for Nuzhat Zeba Rehan Akhtar Ansari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nuzhat Zeba Rehan Akhtar Ansari

Nuzhat Zeba Rehan Akhtar Ansari currently holds 1 directorship: Certus Medicinus Systems Private Limited (Director, since 30 May 2025).

Nuzhat Zeba Rehan Akhtar Ansari was first appointed on 30 May 2025 as Director at Certus Medicinus Systems Private Limited.

The current boards of Nuzhat Zeba Rehan Akhtar Ansari's companies include Jyoti Aggarwal (Certus Medicinus Systems Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available